Background/aim: Meningioma is the most frequent meningeal neoplasm, usually without relapse or metastasis. Patient follow-up is challenging, not standardized and is decided in multidisciplinary case discussion. Our aim was to determine the clinical and histological factors influencing the time to relapse.
Patients and methods: We conducted a single-Center retrospective study on 38 patients with surgically-excised relapsing meningiomas and collected clinical and pathological data.
Results: Our results show that none of the histological factors included in the WHO classification, nor those not included are related to a shorter time to relapse.
Conclusion: In our study, none of the histological, immunohistochemical and clinical parameters evaluated seem to be able to predict the time to relapse in meningioma.
Keywords: Meningioma; WHO classification; human; meningeal neoplasm; recurrent brain tumor.
Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.